Article
Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project.
Postgraduate medical journal - 18 Oct 2024
González-Muñoza Carlos, Calafat Margalida, Gisbert Javier P, Iglesias Eva, Mínguez Miguel, Sicilia Beatriz, Aceituno Montserrat, Gomollón Fernando, Calvet Xavier, Ricart Elena, De Castro Luisa, Rivero Montserrat, Mesonero Francisco, Márquez Lucía, Nos Pilar, Rodríguez-Pescador Ainhoa, Guardiola Jordi, García-Sepulcre MarianaFe, García-López Santiago, Lorente-Poyatos Rufo H, Alba Cristina, Sánchez-Ocaña Ramon, Vera Isabel, Madero Lucía, Riestra Sabino, Navarro-Llavat Mercedes, Pérez-Calle Jose L, Camps Blau, Van Domselaar Manuel, Lucendo Alfredo J, Martín-Arranz Maria Dolores, Montoro-Huguet Miguel A, Sierra-Ausín Mónica, Llaó Jordina, Carpio Daniel, Varela Pilar, Merino Olga, Fernández-Salazar Luis I, Piqueras Marta, Sesé Eva, Busquets David, Tardillo Carlos, Maroto Nuria, Riera Joan, Martínez-Flores Carlos, Muñoz Fernando, Gordillo-Ábalos Jordi, Bertoletti Federico, Garcia-Planella Esther, Domènech Eugeni
Abstract excerpt
BACKGROUND AND AIMS: Familial inflammatory bowel disease (IBD) history is a controversial prognostic factor in IBD. We aimed to evaluate the impact of a familial history of IBD on the use of medical and surgical treatments in the biological era. METHODS: Patients included in the prospectively maintained ENEIDA database and diagnosed with IBD after 2005 were included. Familial forms were defined as those cases...
Read the complete abstract on PubMed